What Rx-360 does

Rx-360 is a nonprofit international pharmaceutical supply chain consortium founded in 2009 and headquartered in Philadelphia, Pennsylvania. The organization is governed by its member companies — which include major pharmaceutical manufacturers (Amgen, Roche, Pfizer, GSK, Boehringer Ingelheim, Hovione), contract manufacturers (Lonza), suppliers (MilliporeSigma), packaging providers (West Pharmaceutical Services), logistics firms (JAS), and tubing manufacturers (NewAge Industries) — under Washington state jurisdiction and operates with 11-50 employees.

The consortium's core product is the trademarked Joint Audit Program® (JAP), supported by the auditsPLUS® cloud-based audit management platform (built on Salesforce) and the web-based Supplier Assessment Questionnaire (SAQ) launched in April 2024. The JAP enables multiple pharmaceutical sponsors to co-fund third-party quality audits of shared suppliers, with members earning audit credits that can be applied to future co-sponsored or licensed audits. Rx-360 supplements these operational products with an extensive publications and tools library covering DSCSA readiness, NMPA compliance, EU GMP Annex 1, GDP checklists, remote auditing, cargo security, tamper-evidence, incident management, and counterfeit prevention, as well as eight active working groups.

Rx-360 generates revenue through annual membership dues (subscription), audit sponsorship and licensing fees, and emerging partnership arrangements (e.g., Leucine FDA Tracker Premium). Distribution is exclusively direct via the membership consortium; the organization has also been designated an APEC Pilot Center of Excellence and collaborates with regulatory bodies (U.S. FDA, USP) and academic institutions (Michigan State University) to extend its influence across global pharmaceutical supply chain governance.

Name

Rx-360

Legal name

Rx-360 Consortium

Website

https://rx-360.org

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Rx-360 is a nonprofit international pharmaceutical supply chain consortium, founded in 2009, that runs the trademarked Joint Audit Program and supporting audit and supplier-assessment platforms for major pharmaceutical manufacturers, contract manufacturers, suppliers, and logistics providers worldwide.

Ownership category

akta.pro rank

Product category

Pharmaceutical Supply Chain Compliance and Joint Auditing

NAICS

Business Support Services (5614)

SIC

Services-Management Services (8741)

akta.pro primary industry

GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP) (HLAGAKAE)

akta.pro secondary industry

Training & Competency Programs for GxP Compliance (HLAGAKAM)

Keywords

• Pharmaceutical supply chain
• Joint audit program
• Supply chain security
• Quality compliance audits
• Supplier qualification

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Dues: Rx-360 operates as a nonprofit international consortium funded through membership dues. Members pay fees to access joint audit programs, receive audit credits, obtain discounts on audit services, and participate in collaborative resource development.
2. Audit Services and Licensing: The organization generates revenue through audit sponsorship fees, licensing fees for audit reports, and credits generated from previously sponsored joint audits that can be applied to future co-sponsored audits.
3. Partnership Services: Rx-360 provides consortium members with access to partner platforms such as Leucine's FDA Tracker Premium, potentially including revenue-sharing or partnership arrangements.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Rx-360 is an international nonprofit consortium that delivers shared third-party pharmaceutical supplier audits through its trademarked Joint Audit Program and auditsPLUS audit management platform. Members and sponsors co-fund supplier quality audits, license audit reports, and accrue transferable audit credits to reduce redundant auditing across the industry. The consortium supplements these core services with member-only resources including the web-based Supplier Assessment Questionnaire, SCAR templates, readiness checklists, and an extensive library of supply-chain-security publications.

Product overview

Rx-360 is a nonprofit international pharmaceutical supply chain consortium offering a platform-plus-services model centered on the Joint Audit Program® (JAP) and auditsPLUS® platform. The core offering includes third-party audit services with shared audit burden among sponsors, supplemented by web-based tools like the Supplier Assessment Questionnaire and SCAR form. The consortium provides an extensive library of publications and guidance documents including white papers on supply chain security, incident management, upstream supply chain security, and cargo theft, along with readiness checklists for regulatory compliance (DSCSA, China NMPA). A Remote Auditing Library provides best practice guides for pharmaceutical auditing. All offerings serve the mission of protecting patient safety by securing the global pharmaceutical supply chain through collaboration, shared audits, and resource development.

Differentiator

Problem solved

Functional benefit

Brands

• Joint Audit Program: Rx-360's trademarked Joint Audit Program provides third-party audit services and brings together multiple sponsors to share the resource burden – managing CAPAs and using audit checklists developed by industry pros from all over the world.

Products and services

• Joint Audit Program® Trademarked third-party audit program that lets multiple pharmaceutical sponsors share the resource burden of auditing the same suppliers, including CAPA management and use of industry-developed audit checklists. Customers are pharmaceutical manufacturers, suppliers, and distributors that need to qualify and re-qualify suppliers more efficiently.
• auditsPLUS® Cloud-based audit management platform that enables members to schedule audits, manage audit reports, and collaborate within the Joint Audit Program. It is available to Rx-360 consortium members and serves the operational backbone of the shared-audit model.
• Supplier Assessment Questionnaire (SAQ) Web-based questionnaire tool covering standard supplier assessment information, designed to reduce inefficiency when each pharmaceutical company individually creates its own supplier assessment. Used by pharmaceutical manufacturers to qualify suppliers and by suppliers to share standardized responses across multiple customers.
• Membership Consortium Annual consortium membership providing access to joint audits, audit credits, discounts on audit program products and services, member-only publications, working group participation, and leadership and speaking opportunities. Customers are pharmaceutical manufacturers, suppliers, distributors, and 3PLs.
• Supplier Corrective Action Report (SCAR) Template Standardized web-based template for issuing, tracking, and resolving supplier corrective actions identified through joint or licensed audits. Intended for pharmaceutical manufacturers, suppliers, and auditors to strengthen supply chain integrity.
• APEC Supply Chain Security Toolkit for Medical Products Comprehensive toolkit providing best practices, standards, and guidance for improving the quality and security of global pharmaceutical supply chains. Developed in partnership with USP and the APEC LSIF, and used by pharmaceutical manufacturers and regulators across the Asia-Pacific region.
• DSCSA Readiness Checklist for Manufacturers Structured checklist distilling DSCSA requirements into actionable steps for pharmaceutical manufacturers, including serialization, EPCIS data exchange, ATP validation, verification systems, and handling of suspect or illegitimate product.
• DSCSA Readiness Checklist for Distributors Actionable DSCSA readiness checklist for wholesale distributors covering ATP verification, serialized EPCIS data exchange, product identifier verification, and suspect/illegitimate product handling procedures.
• 2026 China Regulations Readiness Checklist Structured readiness tool that helps organizations navigate the 2026 China pharmaceutical regulatory reforms (NMPA), covering regulatory monitoring and supply chain security requirements.

Quantifiable outcome

• GSK generated nearly $100,000 in audit credits over 10+ years of membership
• +2 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• LeucinecoreStrategic or Co-development Partner · 25 November 2025Rx-360 announced a partnership with Leucine to provide consortium members with free access to Leucine's FDA Tracker Premium platform. This platform offers real-time FDA inspection and enforcement data to help pharmaceutical manufacturers improve compliance and regulatory readiness.
• Michigan State UniversitycoreStrategic or Co-development PartnerRx-360 is collaborating with Michigan State University's Eli Broad College of Business to develop and offer an educational course on pharmaceutical brand protection and supply chain integrity. The course is led by Jeremy Wilson, professor in MSU's School of Criminal Justice who founded the Center for Anti-Counterfeiting and Product Protection.
• United States Pharmacopeia (USP)coreStrategic or Co-development PartnerRx-360 has been a promoter of the APEC Supply Chain Toolkit from its founding. The APEC Supply Chain Security Toolkit is now hosted by the USP, which supports the Asia Pacific Economic Cooperation Life Sciences Innovation Forum to disseminate best practices and standards that improve pharmaceutical supply chain quality and security.
• APEC (Asia-Pacific Economic Cooperation)coreStrategic or Co-development PartnerRx-360 has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot focuses on the Global Medical Product Supply Chain Integrity Priority Work Area Roadmap, supporting the Asia-Pacific region's efforts in pharmaceutical supply chain security.
• U.S. FDAminorStrategic or Co-development PartnerRx-360 collaborates with the FDA through the APEC Supply Chain Security Toolkit and participates in regulatory harmonization initiatives. The FDA provides subject matter experts for Rx-360 events and workshops on pharmaceutical supply chain security.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• NSF (Health Sciences): NSF's Health Sciences division provides pharma and medical device GMP/GDP consulting, auditor training, and supplier qualification services to manufacturers. It competes with Rx-360's joint audit and training footprint but as part of a much broader testing, inspection, and certification portfolio.
• International Society for Pharmaceutical Engineering (ISPE): ISPE is a large global pharmaceutical industry association delivering training, guidance documents (including GMP guidance), working groups, and conferences. It competes with Rx-360's training and best-practice publications but at much larger scale and broader scope.
• Eurofins Scientific: Eurofins is a global testing, inspection, and certification group with dedicated pharmaceutical services spanning GMP/GDP audits, excipient testing, and supplier qualification. It competes with Rx-360's audit program but as part of a much broader life-sciences testing enterprise.
• Parenteral Drug Association (PDA): PDA is an international industry association for parenteral and sterile pharma manufacturing with strong focus on quality management systems, technical reports, training, and annual meetings. It overlaps with Rx-360's QMS-adjacent content but operates as a much broader industry body.

Direct peers

• Pharmaceutical Supply Chain Initiative (PSCI): PSCI is an industry-led consortium of pharmaceutical and healthcare companies driving responsible supply chain practices, including shared supplier qualification and audit programs. It is the closest analog to Rx-360's consortium-based shared audit model.
• BioPhorum: BioPhorum is a member consortium where biopharma manufacturers collaborate on operational excellence, quality, and supply chain topics through working groups and publications. Its consortium governance and shared-resource model closely mirror Rx-360's structure.
• Concept Heidelberg: Concept Heidelberg organizes GMP/GDP conferences, training courses, and publications for pharmaceutical professionals globally. Its training and guidance offerings compete directly with Rx-360's working group output, webinars, and best practice content.
• Lachman Consultants: Lachman Consultants provides pharmaceutical quality, regulatory, and GMP/GDP compliance consulting including audit remediation and supplier qualification support. It is a direct professional-services competitor for the same pharma manufacturer customers Rx-360 serves.
• International Pharmaceutical Excipients Council (IPEC): IPEC is an international industry association focused on pharmaceutical excipients with GMP guides, supplier qualification frameworks, and global regulatory advocacy. Its focus on excipient supplier qualification overlaps directly with Rx-360's audit and supplier assessment work.

Others

• United States Pharmacopeia (USP): USP sets public pharmaceutical quality standards and now hosts the APEC Supply Chain Security Toolkit in partnership with Rx-360. While complementary rather than competitive, USP's standards and reference standards offerings intersect thematically with Rx-360's quality mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rx-360
• Xx.com/rx_360

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rx-360